Sign inJoin waitlistJoin the waitlist

Daniel Kingsley

Hematology-Oncology · North Alabama Medical Center

Credentials: · · · · · · · ·

History

North Alabama Medical Center
Present

University of Missouri-Columbia, School of Medicine
2009–2010
University of Tennessee Health Science Center College of Medicine
2008–2009
Hematology and Medical Oncology
2005–2008
Hospice and Palliative Medicine
2004–2005
Internal Medicine
University of Alabama Hospital
2001–2004
University of Alabama at Birmingham Marnix E. Heersink School of Medicine
1997–2001

Research

Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial
Blood · 2015 · 65 citations
Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer
Clinical Lung Cancer · 2017 · 36 citations
Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer
Investigational New Drugs · 2014 · 8 citations

Herbert Eradat
2 papers
Jennifer Brown
2 papers
JP
John Pagel
2 papers
SH
Sunpil Hwang
2 papers · 2 as a resident
SO
Susan O'Brien
2 papers
Thomas Kipps
2 papers
Abhinav Vyas
1 paper · 1 as a resident
AA
Asim Ahmad
1 paper · 1 as a fellow
Bassel El-Rayes
1 paper
FB
Fadi Braiteh
1 paper
Heather Wakelee
1 paper
Heinz-Josef Lenz
1 paper